Already a member? Sign in
June 2016, Volume :116 Number 6 , page 23 - 23 [Buy]
Join NursingCenter to get uninterrupted access to this Article
Have a coupon or promotional code? Enter it here:
When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.
* Brivaracetam (Briviact) is a new antiepileptic approved to treat partial-onset seizures.
* The most common adverse effects are somnolence and sedation, dizziness, fatigue, and nausea and vomiting.
Join NursingCenter on Social Media to find out the latest news and special offers
© 2023 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved. – Terms & Conditions – Privacy Policy – Disclaimer -- v08.10.02